Chongqing Medical University Researcher Reports Recent Findings in Fatty Liver Disease (6-Gingerol Inhibits De Novo Lipogenesis by Targeting Stearoyl-CoA Desaturase to Alleviate Fructose-Induced Hepatic Steatosis).

A recent study conducted at Chongqing Medical University in China explored the use of 6-gingerol, an active compound in ginger, to alleviate fructose-induced hepatic steatosis in rats. The research found that 6-gingerol reduced hyperlipidemia and inhibited de novo lipogenesis, targeting stearoyl-CoA desaturase (SCD) to decrease fatty acid desaturation levels. The study suggests that 6-gingerol may be a potential therapeutic option for metabolic-associated fatty liver disease. For more information, the full article can be accessed through the International Journal of Molecular Sciences. [Extracted from the article]